CDMO News
Evotec-Bristol Myers Squibb Partnership Hits $25M Milestone in Neurodegenerative Research
Evotec SE has received a $25 million milestone payment from Bristol Myers Squibb, marking further progress in their strategic partnership focused on advancing neuroscience programs. This milestone underlines the ongoing success of the collaboration, which began in December 2016 and
9 August 2024